Manuel Mendoza
Brownsville, TXNPI 1609828904
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,043,580 of the $1,043,580 with a category attached, or 100.0%. CSL Behring accounts for 75.1% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $219,975 and has fallen 65.0% since, to $77,000 in 2025.
Across 969 payments — averaging $1076.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$784K
- CSL Plasma Inc.$259K
What the payments were for
- Consulting fees$1,043,580100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 667 | $784,230 |
| CSL Plasma Inc. | 302 | $259,350 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.